| First Author | Miao Y | Year | 2019 |
| Journal | Cell Death Dis | Volume | 10 |
| Issue | 7 | Pages | 474 |
| PubMed ID | 31209201 | Mgi Jnum | J:324078 |
| Mgi Id | MGI:6751765 | Doi | 10.1038/s41419-019-1720-0 |
| Citation | Miao Y, et al. (2019) BRCA2 deficiency is a potential driver for human primary ovarian insufficiency. Cell Death Dis 10(7):474 |
| abstractText | Reproductive problem has been one of the top issues for women health worldwide in recent decades. As a typical female disease, primary ovarian insufficiency (POI) results in a loss of ovarian follicles and oocytes that thus destroys women fertility. However, due to the complex of POI etiology and rare resource of human POI oocytes, few biomarkers have been identified in clinics and no effective strategy could be applied to treat POI patients. In the search of possible association between DNA damage and POI by Smart-Seq2 and RT(2) profiler PCR array, we find that BRCA2, a core DNA repair gene for homologous recombination shows significantly lower expression in two POI patient oocytes. In line with this, we generated oocyte-specific knockout mouse model driven by Gdf9-Cre. The Brca2-deficient mice are infertile because of the arrested follicle development and defective oocyte quality caused by the accumulation of DNA damage. Notably, ectopic expression of Brca2 in Brca2-deficient oocytes could partially restore the oocyte maturation and chromosome stability. Collectively, our data assign a definite deficiency to BRCA2 as a POI driver during follicle development and oocyte maturation, and provide a potential fertility treatment strategy for POI patients induced by BRCA2 deficiency. |
